Showing posts with label Dopamine. Show all posts
Showing posts with label Dopamine. Show all posts

Wednesday, March 26, 2014

Schizophrenia 3.0: Salience dysregulation.

This post is prompted by an article published in this February’s Trends in Neurosciences under the title “Dopaminergic Basis of Salience Dysregulation inPsychosis” by Winton-Brown, Fusar-Poli, Ungless, & Howes (2014) and an earlier paper in the Schizophrenia bulletin entitled “The dopamine hypothesisof schizophrenia: version II – the final common pathway” (Howes & Kapur, 2009). As stated in the first title, Winton-Brown et al.’s work reviews extensively what they consider to be evidence of the dopaminergic basis of salience dysregulation and more briefly consider the argument for salience dysregulation as a causal force in the etiology of schizophrenia. Their work was building on an argument made by Howes & Kapur who suggested that a panoply of genetic and environmental risk factors all converge on increased striatal dopaminergic function, producing aberrant salience and thereby psychosis.